Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 055962/0139 | |
| Pages: | 9 |
| | Recorded: | 04/19/2021 | | |
| Attorney Dkt #: | BHCS.P0053US.D2 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/07/2023
|
Application #:
|
17301704
|
Filing Dt:
|
04/12/2021
|
|
Publication #:
|
|
Pub Dt:
|
10/07/2021
| | | | |
|
Title:
|
FUSION PROTEINS COMPRISING AN ANTI-CD40 ANTIBODY AND CANCER ANTIGENS
|
|
|
Assignee
|
|
|
|
|
| 2001 BRYAN STREET |
| SUITE 2200 |
| DALLAS, TEXAS 75201 |
|
|
Correspondence name and address
|
| |
NORTON ROSEFULBRIGHT US LLP
|
| |
98 SAN JACINTO BLVD.
|
| |
SUITE 1100
|
| |
AUSTIN, TX 78701
|
Search Results as of:
06/14/2024 02:59 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
